Bültmann & Gerriets
Children in Medical Research
Access Versus Protection
von Lainie Friedman Ross
Verlag: Oxford University Press
Reihe: Issues in Biomedical Ethics
Gebundene Ausgabe
ISBN: 978-0-19-927328-7
Erschienen am 13.04.2006
Sprache: Englisch
Format: 235 mm [H] x 162 mm [B] x 23 mm [T]
Gewicht: 608 Gramm
Umfang: 300 Seiten

Preis: 115,50 €
keine Versandkosten (Inland)


Jetzt bestellen und voraussichtlich ab dem 20. Oktober in der Buchhandlung abholen.

Der Versand innerhalb der Stadt erfolgt in Regel am gleichen Tag.
Der Versand nach außerhalb dauert mit Post/DHL meistens 1-2 Tage.

115,50 €
merken
klimaneutral
Der Verlag produziert nach eigener Angabe noch nicht klimaneutral bzw. kompensiert die CO2-Emissionen aus der Produktion nicht. Daher übernehmen wir diese Kompensation durch finanzielle Förderung entsprechender Projekte. Mehr Details finden Sie in unserer Klimabilanz.
Klappentext
Biografische Anmerkung
Inhaltsverzeichnis

Lainie Ross presents a rigorous critical investigation of the development of policy governing the involvement of children in medical research. She examines the shift in focus from protection of medical research subjects, enshrined in post-World War II legislation, to the current era in which access is assuming greater precedence. Infamous studies such as Willowbrook (where mentally retarded children were infected with hepatitis) are evidence that before the policy shift protection was not always adequate, even for the most vulnerable groups. Additional safeguards for children were first implemented in many countries in the 1970s and 1980s; more recent policies and guidelines are trying to promote greater participation. Ross examines whether the safeguards work, whether they are fair, and how they apply in actual research practice, and she offers specific recommendations to modify current policies and guidelines.



Dr. Lainie Ross is a general pediatrician and a medical ethicist in the MacLean Center for Clinical Medical Ethics at the University of Chicago.



  • I. Access versus Protection

  • 1: From 1966 to 2005: Balancing Protection and Access in Pediatric Research

  • 2: Access versus Protection: Minority Representation in Pediatric Research

  • II. Challenges to the Regulations

  • 3: Overview of the Common Rule and Subpart D

  • 4: Should We Provide Healthy Children with Greater Protection in Medical Research?

  • 5: Informed Consent in Pediatric Research

  • 6: Phase I Research and the Meaning of 'Prospect of Direct Benefit'

  • III. Strengths and Limits of Current Regulations

  • 7: Human Subjects Protections in Published Pediatric Research

  • 8: Payment in Pediatric Research

  • 9: Research in Schools

  • IV. Case Studies

  • 10: Minimizing Risks: Diabetes Research in Newborns

  • 11: Diabetes Prediction and Prevention Research in Childhood

  • 12: Lead Abatement Research

  • 13: Clinical Asthma Trials

  • 14: Research Not Otherwise Approvable: A Look at One Protocol

  • 15: Evolution of the 407 Process

  • Epilogue


weitere Titel der Reihe